Indeed, the expression dynamics of SOX10 and KIT during melanoma progression reveal an intriguing pattern: SOX10 expression gradually increases throughout disease progression, whereas KIT shows biphasic regulation—upregulated in primary melanoma but subsequently downregulated during metastasis.107. The gene discussed is SOX10; the disease is melanoma.